Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
B-Liv
- Development stage
- Unknown
- Lead developer
- Med Manor Organics
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
B-Liv is a combination hepatoprotective tablet developed by Med Manor Organics. It contains L-ornithine L-aspartate, metadoxine, pyridoxine (vitamin B6), and silymarin. It is primarily indicated for the supportive treatment of acute and chronic liver diseases, including alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD), liver cirrhosis, and chronic hepatitis. L-ornithine L-aspartate helps reduce blood ammonia levels by promoting the urea cycle, metadoxine accelerates alcohol clearance and acts as an antioxidant, silymarin provides antioxidant and anti-inflammatory protection to liver cells, and pyridoxine supports protein metabolism and nerve function.
- Brand names
- B-LivB-Liv Forte
- Other names
- B LivB-Liv Forte TabletB-Liv Tablet
02
Targets
HTR2B (5-Hydroxytryptamine Receptor 2B)CPS1 (Carbamoyl phosphate synthetase I)GLUL (Glutamine synthetase)OTC (Ornithine carbamoyltransferase)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)
Beyond the preview
Go deeper on B-Liv.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on B-Liv.